Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention

Overview of attention for article published in JACC: Cardiovascular Interventions, November 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 6 news stories from 5 outlets.

Medizin Donnerstag, 5. April 2018 /zgr Gven, stockadobecom Chapel Hill/North Carolina Die routinemige Untersuchung des CYP2C19-St…

(HealthDay)—Patients with a CYP2C19 loss-of-function allele have increased risk of major adverse cardiovascular events (MACE…

Patients with a CYP2C19 loss-of-function allele have increased risk of major adverse cardiovascular events with clopidogrel…

FRIDAY, Nov. 3, 2017 (HealthDay News) -- Patients with a CYP2C19 loss-of-function allele have increased risk of major adverse…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 2 additional news stories.